Cargando…
An Evaluation of the Complement-Regulating Activities of Human Complement Factor H (FH) Variants Associated With Age-Related Macular Degeneration
PURPOSE: Factor H (FH, encoded by CFH) prevents activation of the complement system's alternative pathway (AP) on host tissues. FH impedes C3 convertase (C3bBb) formation, accelerates C3bBb decay, and is a cofactor for factor I (FI)–catalyzed C3b cleavage. Numerous CFH variants are associated w...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Association for Research in Vision and Ophthalmology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716232/ https://www.ncbi.nlm.nih.gov/pubmed/36445700 http://dx.doi.org/10.1167/iovs.63.12.30 |
_version_ | 1784842640617897984 |
---|---|
author | Biggs, Robyn M. Makou, Elisavet Lauder, Scott Herbert, Andrew P. Barlow, Paul N. Katti, Suresh K. |
author_facet | Biggs, Robyn M. Makou, Elisavet Lauder, Scott Herbert, Andrew P. Barlow, Paul N. Katti, Suresh K. |
author_sort | Biggs, Robyn M. |
collection | PubMed |
description | PURPOSE: Factor H (FH, encoded by CFH) prevents activation of the complement system's alternative pathway (AP) on host tissues. FH impedes C3 convertase (C3bBb) formation, accelerates C3bBb decay, and is a cofactor for factor I (FI)–catalyzed C3b cleavage. Numerous CFH variants are associated with age-related macular degeneration (AMD), but their functional consequences frequently remain undetermined. Here, we conduct functional comparisons between a control version of FH (not AMD linked) and 21 AMD-linked FH variants. METHODS: Recombinantly produced, untagged, full-length FH versions were assayed for binding to C3b and decay acceleration of C3bBb using surface-plasmon resonance, FI-cofactor activity using a fluorescent probe of C3b integrity, suppression of C5b-9 assembly on an AP-activating surface, and inhibition of human AP-mediated lysis of sheep erythrocytes. RESULTS: All versions were successfully purified despite below-average yields for Arg2Thr, Arg53Cys, Arg175Pro, Arg175Gln, Ile221Val, Tyr402His, Pro503Ala, Arg567Gly, Gly1194Asp, and Arg1210Cys. Compared to control FH, Arg2Thr, Leu3Val, Ser58Ala, Asp90Gly, Asp130Asn, Gln400Lys, Tyr402His, Gly650Val, Ser890Ile, and Thr965Met showed minimal functional differences. Arg1210C, Arg53His, Arg175Gln, Gly1194Asp, Pro503Ala, Arg53Cys, Arg576Gly, and Arg175Pro (in order of decreasing efficacy) underperformed, while Ile221Val, Arg303Gln, and Arg303Trp were “marginal.” We newly identified variants toward the center of the molecule, Pro503Ala and Arg567Gly, as potentially pathogenic. CONCLUSIONS: Our approach could be extended to other variants of uncertain significance and to assays for noncanonical FH activities, aiming to facilitate selection of cohorts most likely to benefit from therapeutic FH. This is timely as recombinant therapeutic FH is in development for intravitreal treatment of AMD in patients with reduced FH functionality. |
format | Online Article Text |
id | pubmed-9716232 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | The Association for Research in Vision and Ophthalmology |
record_format | MEDLINE/PubMed |
spelling | pubmed-97162322022-12-03 An Evaluation of the Complement-Regulating Activities of Human Complement Factor H (FH) Variants Associated With Age-Related Macular Degeneration Biggs, Robyn M. Makou, Elisavet Lauder, Scott Herbert, Andrew P. Barlow, Paul N. Katti, Suresh K. Invest Ophthalmol Vis Sci Biochemistry and Molecular Biology PURPOSE: Factor H (FH, encoded by CFH) prevents activation of the complement system's alternative pathway (AP) on host tissues. FH impedes C3 convertase (C3bBb) formation, accelerates C3bBb decay, and is a cofactor for factor I (FI)–catalyzed C3b cleavage. Numerous CFH variants are associated with age-related macular degeneration (AMD), but their functional consequences frequently remain undetermined. Here, we conduct functional comparisons between a control version of FH (not AMD linked) and 21 AMD-linked FH variants. METHODS: Recombinantly produced, untagged, full-length FH versions were assayed for binding to C3b and decay acceleration of C3bBb using surface-plasmon resonance, FI-cofactor activity using a fluorescent probe of C3b integrity, suppression of C5b-9 assembly on an AP-activating surface, and inhibition of human AP-mediated lysis of sheep erythrocytes. RESULTS: All versions were successfully purified despite below-average yields for Arg2Thr, Arg53Cys, Arg175Pro, Arg175Gln, Ile221Val, Tyr402His, Pro503Ala, Arg567Gly, Gly1194Asp, and Arg1210Cys. Compared to control FH, Arg2Thr, Leu3Val, Ser58Ala, Asp90Gly, Asp130Asn, Gln400Lys, Tyr402His, Gly650Val, Ser890Ile, and Thr965Met showed minimal functional differences. Arg1210C, Arg53His, Arg175Gln, Gly1194Asp, Pro503Ala, Arg53Cys, Arg576Gly, and Arg175Pro (in order of decreasing efficacy) underperformed, while Ile221Val, Arg303Gln, and Arg303Trp were “marginal.” We newly identified variants toward the center of the molecule, Pro503Ala and Arg567Gly, as potentially pathogenic. CONCLUSIONS: Our approach could be extended to other variants of uncertain significance and to assays for noncanonical FH activities, aiming to facilitate selection of cohorts most likely to benefit from therapeutic FH. This is timely as recombinant therapeutic FH is in development for intravitreal treatment of AMD in patients with reduced FH functionality. The Association for Research in Vision and Ophthalmology 2022-11-29 /pmc/articles/PMC9716232/ /pubmed/36445700 http://dx.doi.org/10.1167/iovs.63.12.30 Text en Copyright 2022 The Authors https://creativecommons.org/licenses/by/4.0/This work is licensed under a Creative Commons Attribution 4.0 International License. |
spellingShingle | Biochemistry and Molecular Biology Biggs, Robyn M. Makou, Elisavet Lauder, Scott Herbert, Andrew P. Barlow, Paul N. Katti, Suresh K. An Evaluation of the Complement-Regulating Activities of Human Complement Factor H (FH) Variants Associated With Age-Related Macular Degeneration |
title | An Evaluation of the Complement-Regulating Activities of Human Complement Factor H (FH) Variants Associated With Age-Related Macular Degeneration |
title_full | An Evaluation of the Complement-Regulating Activities of Human Complement Factor H (FH) Variants Associated With Age-Related Macular Degeneration |
title_fullStr | An Evaluation of the Complement-Regulating Activities of Human Complement Factor H (FH) Variants Associated With Age-Related Macular Degeneration |
title_full_unstemmed | An Evaluation of the Complement-Regulating Activities of Human Complement Factor H (FH) Variants Associated With Age-Related Macular Degeneration |
title_short | An Evaluation of the Complement-Regulating Activities of Human Complement Factor H (FH) Variants Associated With Age-Related Macular Degeneration |
title_sort | evaluation of the complement-regulating activities of human complement factor h (fh) variants associated with age-related macular degeneration |
topic | Biochemistry and Molecular Biology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716232/ https://www.ncbi.nlm.nih.gov/pubmed/36445700 http://dx.doi.org/10.1167/iovs.63.12.30 |
work_keys_str_mv | AT biggsrobynm anevaluationofthecomplementregulatingactivitiesofhumancomplementfactorhfhvariantsassociatedwithagerelatedmaculardegeneration AT makouelisavet anevaluationofthecomplementregulatingactivitiesofhumancomplementfactorhfhvariantsassociatedwithagerelatedmaculardegeneration AT lauderscott anevaluationofthecomplementregulatingactivitiesofhumancomplementfactorhfhvariantsassociatedwithagerelatedmaculardegeneration AT herbertandrewp anevaluationofthecomplementregulatingactivitiesofhumancomplementfactorhfhvariantsassociatedwithagerelatedmaculardegeneration AT barlowpauln anevaluationofthecomplementregulatingactivitiesofhumancomplementfactorhfhvariantsassociatedwithagerelatedmaculardegeneration AT kattisureshk anevaluationofthecomplementregulatingactivitiesofhumancomplementfactorhfhvariantsassociatedwithagerelatedmaculardegeneration AT biggsrobynm evaluationofthecomplementregulatingactivitiesofhumancomplementfactorhfhvariantsassociatedwithagerelatedmaculardegeneration AT makouelisavet evaluationofthecomplementregulatingactivitiesofhumancomplementfactorhfhvariantsassociatedwithagerelatedmaculardegeneration AT lauderscott evaluationofthecomplementregulatingactivitiesofhumancomplementfactorhfhvariantsassociatedwithagerelatedmaculardegeneration AT herbertandrewp evaluationofthecomplementregulatingactivitiesofhumancomplementfactorhfhvariantsassociatedwithagerelatedmaculardegeneration AT barlowpauln evaluationofthecomplementregulatingactivitiesofhumancomplementfactorhfhvariantsassociatedwithagerelatedmaculardegeneration AT kattisureshk evaluationofthecomplementregulatingactivitiesofhumancomplementfactorhfhvariantsassociatedwithagerelatedmaculardegeneration |